Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia Praecox”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00946348
What this trial is testing

Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

Who this might be right for
SchizophreniaDual DiagnosisSchizoaffective Disorder+2 more
Dartmouth-Hitchcock Medical Center 12
Large-scale testing (Phase 3)Study completedNCT00249132
What this trial is testing

The Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen, LP 523
Large-scale testing (Phase 3)Study completedNCT00297947
What this trial is testing

High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Manhattan Psychiatric Center 60
Large-scale testing (Phase 3)UnknownNCT02453893
What this trial is testing

Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia

Who this might be right for
Schizophrenia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 288
Large-scale testing (Phase 3)Study completedNCT01541371
What this trial is testing

Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Xian-Janssen Pharmaceutical Ltd. 405
Testing effectiveness (Phase 2)Study completedNCT02810964
What this trial is testing

Sulforaphane to Reduce Symptoms of Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sheppard Pratt Health System 64
Early research (Phase 1)Ended earlyNCT00929370
What this trial is testing

A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.

Who this might be right for
Schizophrenia
GlaxoSmithKline 34
Not applicableStudy completedNCT01619319
What this trial is testing

Effects of Cognitive Remediation on Cognition in Young People at Clinical High Risk of Psychosis

Who this might be right for
Prodromal Schizophrenia
University of Calgary 32
Not applicableUnknownNCT00825045
What this trial is testing

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Centre for Addiction and Mental Health 14
Testing effectiveness (Phase 2)Study completedNCT01649557
What this trial is testing

Multicenter, Open-label, Safety and Tolerability Study

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 244
Not applicableStudy completedNCT04166019
What this trial is testing

Effect of a Peer-led Self-management Program for Recent-onset Psychosis

Who this might be right for
Early PsychosisPsychotic Disorders
Chinese University of Hong Kong 180
Testing effectiveness (Phase 2)UnknownNCT03607630
What this trial is testing

Can Imagination Change Upsetting Memories of Trauma?

Who this might be right for
Psychosis
King's College London 12
Large-scale testing (Phase 3)Study completedNCT01626872
What this trial is testing

Long-Term Study of MP-214 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Tanabe Pharma Corporation 254
Post-approval studies (Phase 4)Study completedNCT02597439
What this trial is testing

Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe

Who this might be right for
Ultra High Risk for Psychosis
Rene Kahn 145
Not applicableStudy completedNCT01558557
What this trial is testing

Gluten Free Diet in People With Schizophrenia: A Pilot Study

Who this might be right for
Gluten SensitivityCeliac Disease
University of Maryland, Baltimore 3
Not applicableStudy completedNCT05936983
What this trial is testing

Comparison of Physical Fitness, Physical Activity Level in Patients With Bipolar Disorder and Schizophrenia

Who this might be right for
Bipolar DisorderSchizophrenia
Yeditepe University 90
Post-approval studies (Phase 4)UnknownNCT06093451
What this trial is testing

Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder

Who this might be right for
Schizophrenia AgitationSchizo Affective DisorderBipolar Disorder+1 more
Temple University 32
Testing effectiveness (Phase 2)Looking for participantsNCT06821945
What this trial is testing

A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Boryung Pharmaceutical Co., Ltd 120
Not applicableStudy completedNCT05100875
What this trial is testing

Social Skills and Emotion Regulation Training "SSERT" for Trauma in Psychosis

Who this might be right for
PsychosisTraumaEmotion Regulation
Douglas Mental Health University Institute 19
Large-scale testing (Phase 3)Study completedNCT01720095
What this trial is testing

Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis

Who this might be right for
Psychosis
Nova Scotia Health Authority 22
Next Page